Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio and Carotid Intima-Media Thickness: A Cohort Study in China. 2021

Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
Department of Biostatistics and Epidemiology, School of Public Health, Shenzhen University Health Science Center, No.1066 Xueyuan Avenue, Nanshan District, Shenzhen, Guangdong, 518060, People's Republic of China.

Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LDL-C/HDL-C) ratio may carry additional information and has been suggested as a better predictor for atherosclerosis progression and cardiovascular disease (CVD) than LDL-C and HDL-C alone. Therefore, we aim to explore the association between LDL-C/HDL-C ratio and high carotid intima-media thickness (CIMT) risk in a large Cohort in Beijing, China. This cohort study included 13,612 adults without high CIMT at first entry and who attended the baseline examination and at least one follow-up annual examination between 2009 and 2016. We used multivariable Cox regression to estimate hazard ratios (HR) with their 95% confidence intervals (CI) for the association between LDL-C/HDL-C ratio and risk of high CIMT. During 37,912 person-years of follow-up, 1996 (1268 men and 728 women) developed high CIMT. Compared with the first quartile of LDL-C/HDL-C ratio, the risk of high CIMT was significantly increased for the fourth quartile of LDL-C/HDL-C ratio (HR = 1.51, 95% CI: 1.29-1.78). We observed a significant association between LDL-C/HDL-C ratio and high CIMT risk comparing LDL-C/HDL-C ratio >2.78 with LDL-C/HDL-C ratio ≤2.78 and significant dose-response relationship between LDL-C/HDL-C ratio and risk of high CIMT. The restricted cubic spline showed a significant nonlinear association between LDL-C/HDL-C ratio and the risk of high CIMT (pnon-linearity = 0.009). We identify a significant association between LDL-C/HDL-C ratio and the risk of high CIMT in the Chinese Cohort study. Future studies are needed to evaluate the effectiveness of reducing LDL-C/HDL-C ratio treatment on the development of high CIMT.

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
October 2022, Vascular,
Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
December 2022, BMC endocrine disorders,
Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
June 2016, Stroke,
Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
January 2023, Cerebrovascular diseases (Basel, Switzerland),
Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
July 2020, Lipids in health and disease,
Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
April 2018, Biomarkers in medicine,
Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
December 2023, BMC public health,
Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
January 2018, Journal of atherosclerosis and thrombosis,
Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
October 2015, Lipids in health and disease,
Pei Qin, and Jing Shi, and Liming Cao, and Xue Li, and Yanmei Lou, and Changyi Wang, and Jianping Ma, and Li Wang, and Xiaolin Peng, and Hongen Chen, and Shan Xu, and Ping Zhao, and Dongsheng Hu, and Fulan Hu
January 2017, Journal of clinical lipidology,
Copied contents to your clipboard!